Prognostic value of a novel interferon-inducible 90K tumor antigen.
D'Ostilio
N
N
Cattedra Oncologia Medica, Università G. d'Annunzio, Chieti, Italy.
Natoli
C
C
Grassadonia
A
A
Rossi
N
N
Di Stefano
P
P
Amatetti
C
C
Tinari
N
N
Iacobelli
S
S
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor / Q000096:biosynthesis* / Q000097:blood* / Q000378:metabolism; D001943:Breast Neoplasms / Q000097:blood / Q000378:metabolism*; D018938:Caco-2 Cells / Q000187:drug effects* / Q000378:metabolism*; D002352:Carrier Proteins; D006023:Glycoproteins; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000494:pharmacology*; D007372:Interferons / Q000502:physiology; D008074:Lipoproteins / Q000096:biosynthesis* / Q000097:blood* / Q000378:metabolism; D009363:Neoplasm Proteins / Q000096:biosynthesis* / Q000097:blood* / Q000378:metabolism; D009364:Neoplasm Recurrence, Local / Q000097:blood* / Q000175:diagnosis*; D011237:Predictive Value of Tests; D011379:Prognosis; D012333:RNA, Messenger / Q000096:biosynthesis; D011994:Recombinant Proteins; D014407:Tumor Cells, Cultured / Q000187:drug effects; D016326:Extracellular Matrix Proteins
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D002352:Carrier Proteins; D006023:Glycoproteins; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D007372:Interferons; D008074:Lipoproteins; D009363:Neoplasm Proteins; D012333:RNA, Messenger; D011994:Recombinant Proteins; C081856:LGALS3BP protein, human; D016326:Extracellular Matrix Proteins